Academic Drug Discovery Centres

The Economic and Organisational Sustainability of an Emerging Model Review

Henriette Schultz Kirkegaard, Finn Valentin

    Research output: Contribution to journalJournal articleResearchpeer-review

    Abstract

    Academic drug discovery centres (ADDCs) are seen as one of the solutions to fill the innovation gap in early drug discovery, which has proven challenging for previous organisational models. Prior studies of ADDCs have identified the need to analyse them from the angle of their economic and organisational sustainability. We take that angle in an in-depth study of four prominent ADDCs. Our findings indicate that there are clear similarities in the way sustainable centres are organised, managed and financed. We also identify factors in the frameworks of academia and research funding affecting their performance.
    Original languageEnglish
    JournalDrug Discovery Today
    Volume19
    Issue number11
    Pages (from-to)1699-1710
    ISSN1359-6446
    DOIs
    Publication statusPublished - 2014

    Cite this

    @article{34857be88406481c8bb7b4249c668825,
    title = "Academic Drug Discovery Centres: The Economic and Organisational Sustainability of an Emerging Model Review",
    abstract = "Academic drug discovery centres (ADDCs) are seen as one of the solutions to fill the innovation gap in early drug discovery, which has proven challenging for previous organisational models. Prior studies of ADDCs have identified the need to analyse them from the angle of their economic and organisational sustainability. We take that angle in an in-depth study of four prominent ADDCs. Our findings indicate that there are clear similarities in the way sustainable centres are organised, managed and financed. We also identify factors in the frameworks of academia and research funding affecting their performance.",
    author = "Kirkegaard, {Henriette Schultz} and Finn Valentin",
    year = "2014",
    doi = "10.1016/j.drudis.2014.06.011",
    language = "English",
    volume = "19",
    pages = "1699--1710",
    journal = "Drug Discovery Today",
    issn = "1359-6446",
    publisher = "Elsevier Ltd. * Trends Journals",
    number = "11",

    }

    Academic Drug Discovery Centres : The Economic and Organisational Sustainability of an Emerging Model Review. / Kirkegaard, Henriette Schultz; Valentin, Finn.

    In: Drug Discovery Today, Vol. 19, No. 11, 2014, p. 1699-1710.

    Research output: Contribution to journalJournal articleResearchpeer-review

    TY - JOUR

    T1 - Academic Drug Discovery Centres

    T2 - The Economic and Organisational Sustainability of an Emerging Model Review

    AU - Kirkegaard, Henriette Schultz

    AU - Valentin, Finn

    PY - 2014

    Y1 - 2014

    N2 - Academic drug discovery centres (ADDCs) are seen as one of the solutions to fill the innovation gap in early drug discovery, which has proven challenging for previous organisational models. Prior studies of ADDCs have identified the need to analyse them from the angle of their economic and organisational sustainability. We take that angle in an in-depth study of four prominent ADDCs. Our findings indicate that there are clear similarities in the way sustainable centres are organised, managed and financed. We also identify factors in the frameworks of academia and research funding affecting their performance.

    AB - Academic drug discovery centres (ADDCs) are seen as one of the solutions to fill the innovation gap in early drug discovery, which has proven challenging for previous organisational models. Prior studies of ADDCs have identified the need to analyse them from the angle of their economic and organisational sustainability. We take that angle in an in-depth study of four prominent ADDCs. Our findings indicate that there are clear similarities in the way sustainable centres are organised, managed and financed. We also identify factors in the frameworks of academia and research funding affecting their performance.

    U2 - 10.1016/j.drudis.2014.06.011

    DO - 10.1016/j.drudis.2014.06.011

    M3 - Journal article

    VL - 19

    SP - 1699

    EP - 1710

    JO - Drug Discovery Today

    JF - Drug Discovery Today

    SN - 1359-6446

    IS - 11

    ER -